Nastassia Samal ImmunoGen (NASDAQ:IMGN) added ~6% premarket Thursday after announcing that the 30-day Hart-Scott-Rodino (HSR) waiting period in relation to its M&A agreement with AbbVie (NYSE:ABBV) expired without any action…
Mohamad Faizal Bin Ramli Investors will keep a close eye on some of the leading drugmakers this week as the healthcare earnings season gets into high gear for Big Pharma,…
designer491 Shares of Standard BioTools (NASDAQ:LAB) and SomaLogic (NASDAQ:SLGC) traded lower on Friday after the shareholders of both lab tool makers approved the recently announced merger agreement between the two.…
Maria Vonotna November was a month to remember for biotech stocks as gene therapy developers outperformed and pharma giants looked for M&A opportunities in the industry amid an improving macro…
Dilok Klaisataporn As 2023 draws to a close, Moody’s Investors Service said in a recent report that the full-year outlook for health insurers remains stable despite upcoming challenges from changes…